Universität zu Köln

Journal Article

Hirsch, Caroline, Park, Yun Soo, Piechotta, Vanessa, Li Chai, Khai, Estcourt, Lise J., Monsef, Ina, Salomon, Susanne, Wood, Erica M., So-Osman, Cynthia, McQuilten, Zoe, Spinner, Christoph D., Malin, Jakob J. ORCID: 0000-0002-2989-0436, Stegemann, Miriam, Skoetz, Nicole and Kreuzberger, Nina ORCID: 0000-0001-8922-0488 (2022). SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19. Cochrane Database Syst Rev. (6). HOBOKEN: WILEY. ISSN 1361-6137

Kreuzberger, Nina ORCID: 0000-0001-8922-0488, Hirsch, Caroline, Andreas, Marike, Boehm, Lena, Broeckelmann, Paul J., Di Cristanziano, Veronica, Golinski, Martin, Hausinger, Renate Ilona, Mellinghoff, Sibylle ORCID: 0000-0003-3928-2503, Lange, Berit, Lischetzki, Tina, Kappler, Verena, Mikolajewska, Agata, Monsef, Ina, Park, Yun Soo, Piechotta, Vanessa, Schmaderer, Christoph, Stegemann, Miriam, Vanshylla, Kanika ORCID: 0000-0003-4552-9170, Weber, Florencia, Weibel, Stephanie, Stephani, Caspar and Skoetz, Nicole (2022). Immunity after COVID-19 vaccination in people with higher risk of compromised immune status: a scoping review. Cochrane Database Syst Rev. (8). HOBOKEN: WILEY. ISSN 1361-6137

Kreuzberger, Nina, Hirsch, Caroline, Li Chai, Khai, Tomlinson, Eve ORCID: 0000-0002-0969-602X, Khosravi, Zahra, Popp, Maria, Neidhardt, Miriam, Piechotta, Vanessa, Salomon, Susanne, Valk, Sarah J., Monsef, Ina, Schmaderer, Christoph, Wood, Erica M., So-Osman, Cynthia, Roberts, David J., McQuilten, Zoe, Estcourt, Lise J. and Skoetz, Nicole (2021). SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. (9). HOBOKEN: WILEY. ISSN 1361-6137

Piechotta, Vanessa, Mellinghoff, Sibylle C., Hirsch, Caroline ORCID: 0000-0002-2011-1010, Brinkmann, Alice, Iannizzi, Claire, Kreuzberger, Nina ORCID: 0000-0001-8922-0488, Adams, Anne ORCID: 0000-0003-3286-1131, Monsef, Ina, Stemler, Jannik, Cornely, Oliver A. ORCID: 0000-0001-9599-3137, Broeckelmann, Paul J. and Skoetz, Nicole (2022). Effectiveness, immunogenicity, and safety of COVID-19 vaccines for individuals with hematological malignancies: a systematic review. Blood Cancer J., 12 (5). LONDON: SPRINGERNATURE. ISSN 2044-5385